BAT Says Potential COVID-19 Vaccine Using Tobacco Leaves Ready For Human Trials

By: Gyarmati Orsolya Date: 2020. 05. 15. 08:50

World’s No.2 cigarette company British American Tobacco said it was ready to test its potential COVID-19 vaccine using proteins from tobacco leaves on humans, after it generated a positive immune response in pre-clinical trials.

The maker of Lucky Strike cigarette said once it gets approval from the US Food and Drug administration (FDA) for the vaccine, it would progress to Phase 1 trials or testing on humans.

The company raised eyebrows in April when it said it was developing a COVID-19 vaccine from tobacco leaves and could produce 1 million to 3 million doses per week if it got the support of government agencies and the right manufacturers.

ESM